Axis Focused Fund
Direct · GrowthAI Summary
Axis Focused Fund has delivered a 10Y SIP XIRR of 12.69% and a 12Y SIP XIRR of 12.64%, trailing the category average SIP XIRR of 15.79% and 15.27% respectively. Against the NIFTY 50, the fund shows strong long-term outperformance with a 12Y lump-sum CAGR of 13.05% versus the benchmark's 9.79% and positive alpha of 3.55%. However, recent performance is mixed: 1Y alpha is a healthy 6.39%, while 5Y alpha is negative at -1.13%.
The fund exhibits a consistently defensive profile, with downside capture below 90% across most windows (88.7% over 10Y, 88.05% over 15Y) and upside capture around 92%, indicating it protects capital in declines at some cost to rallies. Beta of roughly 0.90-0.96 confirms lower volatility than the NIFTY 50. Calmar ratios of 0.42-0.46 across all durations reflect steady risk-adjusted returns, though the fund has experienced 8 drawdown events exceeding 10%.
The 28-stock focused portfolio is led by ICICI Bank (7.59%), Eternal (6.09%), and Divi's Laboratories (5.27%), with financials dominating — Banks at 18.4% plus Finance at 8.9% means over 27% in financial services. Healthcare exposure is notable through Divi's Labs and Apollo Hospitals (combined ~10.4%). The concentrated 28-holding structure amplifies single-stock and sector risk, though the top 10 holdings sum to a moderate ~47.9%.
The fund lags category peers on SIP XIRR across every horizon, underperforming the category average by roughly 2-3 percentage points at 3Y (13.93% vs 16.4%) and 10Y (12.69% vs 15.79%). Lump-sum rolling returns tell a better story, with 10Y rolling mean of 14.02% exceeding the benchmark CAGR of 10.79%. This suggests relative strength for lump-sum investors but weaker recent SIP outcomes versus peers.
This fund suits investors seeking large-cap-tilted, lower-beta market exposure with a long horizon of 7+ years, as evidenced by consistent long-term alpha over the NIFTY 50. Its defensive downside capture makes it appropriate for moderate risk tolerance rather than aggressive return-chasers. SIP investors should note the current category underperformance and consider whether the defensive style fits their goals.
- Consistent long-term outperformance versus NIFTY 50, with 12Y alpha of 3.55% and 15Y alpha of 2.85%
- Strong downside protection with downside capture of 88.7% over 10Y and 88.05% over 15Y
- Low beta of 0.90-0.96 with stable Calmar ratios around 0.42-0.46 across all time horizons
- SIP XIRR trails the category average across all horizons, including 13.93% vs 16.4% at 3Y and 12.69% vs 15.79% at 10Y
- Negative 5Y alpha of -1.13% versus NIFTY 50 indicates recent lump-sum underperformance against the benchmark
- Heavy financial sector concentration of over 27% (Banks 18.4% plus Finance 8.9%) in a focused 28-stock portfolio
Generated on 02-09-2026, 2:56 AM. Verify before investing.
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
If you invested ₹1,00,000 every month via SIP, here's how this fund has historically performed across different time horizons.
| Duration | Invested | Median Value | XIRR | Min XIRR | Max XIRR |
|---|---|---|---|---|---|
| 1 Year | ₹12.00 L | ₹12.79 L | 16.3% | -45.2% | 89.1% |
| 3 Years | ₹36.00 L | ₹43.69 L | 13.9% | -11.7% | 38.1% |
| 5 Years | ₹60.00 L | ₹82.41 L | 13.7% | 0.4% | 26.5% |
| 7 Years | ₹84.00 L | ₹1.31 Cr | 13.4% | 5.7% | 22.9% |
| 10 Years | ₹1.20 Cr | ₹2.32 Cr | 12.7% | 8.5% | 16.0% |
| 12 Years | ₹1.44 Cr | ₹3.27 Cr | 12.6% | 9.7% | 15.1% |
SIP returns vs benchmark & category
Annualised SIP return (XIRR) over each rolling horizon — like-for-like, not lump-sum.
| Duration | Fund SIP XIRR | NIFTY 50 | Category avg | Fund edge |
|---|---|---|---|---|
| 1 Year | 16.3% | 14.4% | 17.0% | +1.8% |
| 3 Years | 13.9% | 11.1% | 16.4% | +2.8% |
| 5 Years | 13.7% | 10.4% | 15.3% | +3.2% |
| 7 Years | 13.4% | 10.6% | 15.2% | +2.8% |
| 10 Years | 12.7% | 11.5% | 15.8% | +1.2% |
| 12 Years | 12.6% | 11.4% | 15.3% | +1.3% |
| Duration | Mean | Median | Min | Max | Sharpe | Sortino | % Positive | Cat. Mean | Cat. Median |
|---|---|---|---|---|---|---|---|---|---|
| 1 Year | 15.5% | 12.6% | -19.4% | 77.6% | 0.49 | 1.36 | 81% | — | — |
| 3 Years | 14.2% | 14.4% | 2.4% | 27.1% | 1.56 | 17.66 | 100% | — | — |
| 5 Years | 14.3% | 14.2% | 5.1% | 25.2% | 1.81 | 75.33 | 100% | — | — |
| 10 Years | 14.0% | 13.8% | 11.1% | 16.4% | 6.21 | — | 100% | — | — |
Calmar Ratio by Duration
Compared against NIFTY 50
| Duration | Alpha | Beta | Upside Capture | Downside Capture | Fund CAGR | Bench CAGR |
|---|---|---|---|---|---|---|
| 1 Year | +6.39 | 0.96 | 98.3% | 89.3% | 3.9% | -2.9% |
| 3 Years | +5.21 | 0.92 | 96.3% | 89.1% | 12.9% | 7.8% |
| 5 Years | -1.13 | 0.94 | 92.8% | 93.2% | 6.6% | 7.8% |
| 7 Years | +0.85 | 0.90 | 91.8% | 90.3% | 12.1% | 11.8% |
| 10 Years | +2.20 | 0.90 | 91.9% | 88.7% | 12.6% | 10.8% |
| 12 Years | +3.55 | 0.91 | 93.6% | 89.0% | 13.1% | 9.8% |
| 15 Years | +2.85 | 0.90 | 92.3% | 88.0% | 12.3% | 9.7% |
| # | Stock | % of NAV |
|---|---|---|
| 1 | ICICI Bank Limited | 7.59% |
| 2 | Eternal Limited | 6.09% |
| 3 | Divi's Laboratories Limited | 5.27% |
| 4 | Apollo Hospitals Enterprise Limited | 5.12% |
| 5 | Cholamandalam Investment and Finance Company Ltd | 4.61% |
| 6 | Bajaj Finance Limited | 4.28% |
| 7 | State Bank of India | 4.16% |
| 8 | PB Fintech Limited | 3.96% |
| 9 | Apar Industries Limited | 3.51% |
| 10 | Axis Bank Limited | 3.34% |